Stock Price
0.47
Daily Change
0.06 13.41%
Monthly
-3.13%
Yearly
365.00%
Q1 Forecast
0.40

Starpharma Holdings reported AUD11.7M in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Medical Developments International AUD 21.61M 11.59M Dec/2025
Mesoblast USD 56.15M 32.57M Jun/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025